Found 6 matching trials
PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients PHASE2 There is a lack of strategies for patients who progress after responding to...
Show More Location
Complexo Hospitalario Universitario de A Coruña
Learn More & Join Trial
The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors PHASE1 The study consists of the two parts, the first one is SHR7390 combined with...
Show More Location
The Cancer Center,Sun Yat-sen University
Learn More & Join Trial
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy N/A The Serpentine (Stratify cancER PatiENTs by ImmuNosupprEssion) project, rep...
Show More Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Learn More & Join Trial
A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy N/A This is an observational precision oncology study designed to collect and a...
Show More Location
Froedtert Hospital and the Medical College of Wisconsin
Learn More & Join Trial
Clinical Trial of Phenformin in Combination With BRAF Inhibitor + MEK Inhibitor for Patients With BRAF-mutated Melanoma PHASE1 The purpose of this study is to test whether it is safe to give phenformin ...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Biopsy- and Biology-driven Optimization of Targeted Therapy in Subjects With Advanced Melanoma PHASE2 This is an open-label, multi-center, clinical phase II study to explore the...
Show More Location
National Centre for Tumour Diseases (NCT)
Learn More & Join Trial